SGLT2 inhibitors activate pantothenate kinase in the human heart
Nicholas Forelli, Trace Thome, Deborah Eaton…·Zoltan Pierre Arany
This study identifies that SGLT2 inhibitors activate pantothenate kinase 1 (PANK1) in the human heart, enhancing coenzyme-A synthesis and fuel use, which may explain their clinical benefits in heart failure.